I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase 1 Clinical Trial of Trametinib and Ponatinib in Patie..:
Kathryn C. Arbour, MD
;
Eusebio Manchado, PhD
;
Matthew J. Bott, MD
...
http://www.sciencedirect.com/science/article/pii/S2666364321001156. , 2022
Link:
https://doi.org/10.1016/j.jtocrr.2021.100256
RT Journal T1
Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS Mutations
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:08ab67b4ab914fc8921cb36a60feebfe&Exemplar=1&LAN=DE A1 Kathryn C. Arbour, MD A1 Eusebio Manchado, PhD A1 Matthew J. Bott, MD A1 Linda Ahn, NP A1 Yosef Tobi, BA A1 Andy Ai Ni A1 Helena A. Yu, MD A1 Alyssa Shannon, BA A1 Marc Ladanyi, MD A1 Victoria Perron, BS A1 Michelle S. Ginsberg, MD A1 Amanda Johnson, BA A1 Andrei Holodny, MD A1 Mark G. Kris, MD A1 Charles M. Rudin, MD, PhD A1 Piro Lito, MD, PhD A1 Neal Rosen, MD, PhD A1 Scott Lowe, PhD A1 Gregory J. Riely, MD, PhD PB Elsevier YR 2022 K1 NSCLC K1 KRAS K1 targeted therapy K1 MEK K1 FGFR1 K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF http://www.sciencedirect.com/science/article/pii/S2666364321001156 LK http://dx.doi.org/https://doi.org/10.1016/j.jtocrr.2021.100256 DO https://doi.org/10.1016/j.jtocrr.2021.100256 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)